Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Trenkwalder

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
MMW Fortschritte Der Medizin|November 15, 2008
[Combined drug therapy is better: successfully protecting elderly hypertensive patients]Peter Trenkwalder
MMW Fortschritte Der Medizin|July 11, 2022
[Hypertension in all situations]Peter Trenkwalder, Bernd Sanner
Deutsche Medizinische Wochenschrift (1946)|October 22, 2015
[Primary and secondary prevention of stroke]Peter Trenkwalder, Andreas Rüchardt
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 13, 2002
Therapy in the elderly hypertensivePeter A Meredith, Peter Trenkwalder
Current Medical Research and Opinion|September 14, 2006
Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS studyHeinrich Holzgreve, Teut Risler, Peter Trenkwalder
Expert Opinion on Pharmacotherapy|October 18, 2011
Efficacy and safety of a fixed-dose combination of lercanidipine and enalapril in daily practice. A comparison of office, self-measured and ambulatory blood pressureJürgen Scholze, Peter Bramlage, Peter Trenkwalder, et al.
Clinical Drug Investigation|May 26, 2007
Efficacy and Safety of Valsartan 160mg/Hydrochlorothiazide 25mg Combination in Patients with Hypertension not Adequately Controlled by Valsartan 160mg/Hydrochlorothiazide 12.5mgPeter Trenkwalder, Hans-Joachim Ulmer, Gottfried Weidinger, et al.
Current Medical Research and Opinion|March 5, 2009
Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertensionThomas W Littlejohn, Peter Trenkwalder, Geert Hollanders, et al.
International Journal of Molecular Sciences|April 25, 2019
European Patent in Immunoncology: From Immunological Principles of Implantation to Cancer TreatmentFranziska M Würfel, Christoph Winterhalter, Peter Trenkwalder, et al.
Journal of Hypertension|July 17, 2004
The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomizationHans Lithell, Lennart Hansson, Ingmar Skoog, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
MMW Fortschritte Der Medizin|November 15, 2008
[Combined drug therapy is better: successfully protecting elderly hypertensive patients]Peter Trenkwalder
MMW Fortschritte Der Medizin|July 11, 2022
[Hypertension in all situations]Peter Trenkwalder, Bernd Sanner
Deutsche Medizinische Wochenschrift (1946)|October 22, 2015
[Primary and secondary prevention of stroke]Peter Trenkwalder, Andreas Rüchardt
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 13, 2002
Therapy in the elderly hypertensivePeter A Meredith, Peter Trenkwalder
Current Medical Research and Opinion|September 14, 2006
Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS studyHeinrich Holzgreve, Teut Risler, Peter Trenkwalder
Expert Opinion on Pharmacotherapy|October 18, 2011
Efficacy and safety of a fixed-dose combination of lercanidipine and enalapril in daily practice. A comparison of office, self-measured and ambulatory blood pressureJürgen Scholze, Peter Bramlage, Peter Trenkwalder, et al.
Clinical Drug Investigation|May 26, 2007
Efficacy and Safety of Valsartan 160mg/Hydrochlorothiazide 25mg Combination in Patients with Hypertension not Adequately Controlled by Valsartan 160mg/Hydrochlorothiazide 12.5mgPeter Trenkwalder, Hans-Joachim Ulmer, Gottfried Weidinger, et al.
Current Medical Research and Opinion|March 5, 2009
Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertensionThomas W Littlejohn, Peter Trenkwalder, Geert Hollanders, et al.
International Journal of Molecular Sciences|April 25, 2019
European Patent in Immunoncology: From Immunological Principles of Implantation to Cancer TreatmentFranziska M Würfel, Christoph Winterhalter, Peter Trenkwalder, et al.
Journal of Hypertension|July 17, 2004
The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomizationHans Lithell, Lennart Hansson, Ingmar Skoog, et al.
Pageof 3